Merck gets priority review for Welireg for PPGL
The FDA has accepted Merck's (MRK) supplemental NDA with priority review for its drug Welireg for the treatment of a rare ...
rheumatologyadvisor4d
Nipocalimab Gets Priority Review for Generalized Myasthenia Gravis
The FDA has granted Priority Review to nipocalimab for the treatment of antibody positive patients with generalized myasthenia gravis.
Monthly Prescribing Reference5d
Novel Therapy for Pyruvate Dehydrogenase Complex Deficiency Gets Priority Review
A Prescription Drug User Fee Act target date of May 27, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application ...
PharmiWeb6d
FDA Grants Priority Review to Merck’s Application…
has accepted for priority review a supplemental new drug application (sNDA) seeking approval of WELIREG ® (belzutifan), Merck’s oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, for the ...
GlobalData on MSN6d
MSD wins FDA priority review for Welireg in rare endocrine cancer
The US Food and Drug Administration (FDA) will soon decide on whether to expand the label of MSD’s Welireg (belzutifan) to ...
Endocrinology Advisor6d
Belzutifan Gets Priority Review for Advanced Pheochromocytoma and Paraganglioma
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for belzutifan for the treatment of adult and pediatric patients aged 12 years and ...
Starlink Internet Review: Is the Satellite Internet Provider Worth the High Cost?
Starlink has the potential to offer faster speeds than Hughesnet or Viasat (not to mention other popular rural internet ...
Targeted Oncology6d
FDA Grants Belzutifan Priority Review For Advanced Pheochromocytoma and Paraganglioma
The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025. The FDA granted priority review to a supplemental new ...
6 Priorities For Education. What We Want For K-12 And Higher Education
Discover our shared priorities for education and learn what we can do to create opportunities for growth and contribution for ...
The Pharma Letter6d
Merck’s Welireg sNDA accepted for priority review in PPGL
The US Food and Drug Administration (FDA) has accepted for priority review a supplemental new drug application (sNDA) for Welireg (belzutifan), Merck & Co’s (NYSE: MRK) oral hypoxia-inducible factor-2 ...